NASDAQ: CMMB
Chemomab Therapeutics Ltd Earnings Dates, Reports, Calls

Chemomab Therapeutics earnings were -$14.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CMMB earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$3.5M, down 4.1% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CMMB reported annual earnings of -$24.2M, with -12.4% growth. The next CMMB earnings date is Mar 5, 2025.

CMMB earnings history

Current Revenue
$0.0
Current Earnings
-$14.4M
Current Profit Margin
0%

CMMB Return on Equity

Current Company
-101.7%
Current Industry
19.9%
Current Market
35%
CMMB's Return on Equity (-101.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CMMB undefined

Current Company
-76.2%
Current Industry
1.3%
CMMB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CMMB announces earnings.

CMMB undefined

Current Company
-87.01%
Current Industry
14.3%
CMMB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CMMB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CMMBN/A-$14.40MN/A-$0.96
UBX-$18.15M-$19.05MN/A-$1.07
OKYO-$10.35M-$10.69MN/A-$0.38
VYNE-$34.00M-$34.00MN/A$3.38
INKT-$13.57M-$13.78MN/A-$3.80

CMMB earnings dates

Next earnings date
Mar 5, 2025

Chemomab Therapeutics Earnings Reports & History FAQ

What were Chemomab Therapeutics's earnings last quarter?

On CMMB's earnings call on Invalid Date, Chemomab Therapeutics (NASDAQ: CMMB) reported Q3 2024 earnings per share (EPS) of -$0.20, up 41.18% year over year. Total CMMB earnings for the quarter were -$3.48 million. In the same quarter last year, Chemomab Therapeutics's earnings per share (EPS) was -$0.34.

If you're new to stock investing, here's how to buy Chemomab Therapeutics stock.

When does Chemomab Therapeutics report earnings?

The next CMMB earnings date is Invalid Date. Add CMMB to your watchlist to be reminded of Chemomab Therapeutics's next earnings date.

What was CMMB's earnings growth in the past year?

As of Chemomab Therapeutics's earnings date in Invalid Date, Chemomab Therapeutics's earnings has grown year over year. CMMB earnings in the past year totalled -$14.40 million.

Is Chemomab Therapeutics profitable or losing money?

As of the last Chemomab Therapeutics earnings report, Chemomab Therapeutics is currently losing money. Chemomab Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$14.40 million, a 50.48% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.